Preventing Radial Artery Occlusion by Using Reverse Barbeau Assessment: Bringing Evidence-Based Practice to the Bedside

2015 ◽  
Vol 35 (4) ◽  
pp. 77-82 ◽  
Author(s):  
Colleen Bonnett ◽  
Nancy Becker ◽  
Brenda Hann ◽  
Annette Haynes ◽  
Jennifer Tremmel
2021 ◽  
Author(s):  
Sachiko Takamatsu ◽  
Nobuyuki Kagiyama ◽  
Naohiko Sone ◽  
Kiyotaka Tougi ◽  
Shuichiro Yamauchi ◽  
...  

Abstract Protocols for hemostasis after trans-radial approach (TRA) vary depending on the institute as there is no established evidence-based protocol. This study aimed to investigate the clinical implications of radial compression protocols. Consecutive patients who underwent outpatient invasive catheter angiography before and after April 2018 were treated with traditional and new protocols, respectively. Using the same hemostasis band, the amount and timing of deflation were fixed in the traditional protocol, whereas the air was removed as much as possible every 30 min in the new protocol. A total of 1,842 patients (71±10 years old, 77% male) were included. Compared with the traditional protocol group (n=1,001), the new protocol group (n=841) had a significantly lower rate of dual antiplatelet therapy (24% vs. 35%, p<0.001). The time required for complete hemostasis was approximately one-third with the new protocol (66±32 min vs. 190±16 min, p<0.001) with no clinically relevant bleeding. The incidence of radial artery occlusion (RAO) was 9.8% and 0.9% in the traditional and new protocol groups, respectively (p<0.001). After adjusting for covariates, the new protocol was associated with a shorter hemostasis time (odds ratio 0.01, p<0.001) and a reduced risk of RAO (odds ratio 0.09, p<0.001). Our new protocol for hemostasis after TRA was strongly associated with a shorter hemostasis time and a lower rate of RAO.


2021 ◽  
Vol 14 (10) ◽  
pp. 1160-1161
Author(s):  
Adel Aminian ◽  
Maarten A.H. van Leeuwen ◽  
Juan F. Iglesias

2019 ◽  
Vol 71 (1) ◽  
Author(s):  
Mohamed A. Sadaka ◽  
Waleed Etman ◽  
Walid Ahmed ◽  
Saeed Kandil ◽  
Salah Eltahan

2017 ◽  
Vol 10 (1) ◽  
pp. 103
Author(s):  
Michael Koutouzis ◽  
Christos Maniotis ◽  
Grigorios Avdikos

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Surya Dharma ◽  
William Kamarullah ◽  
Nurcahyani ◽  
Rachmatu Bill Multazam ◽  
Claudia Mary Josephine

2021 ◽  
Author(s):  
Matthaios Didagelos ◽  
Areti Pagiantza ◽  
Thomas Zegkos ◽  
Christos Papanastasiou ◽  
Konstantina Zarra ◽  
...  

Radial artery occlusion (RAO) is the commonest complication of transradial catheterization. There is no evidence-based therapy, in the frame of a randomized control study, for the treatment of RAO. The purpose of the LOW-RAO study is to question the hypothesis if low-molecular-weight heparin is effective in the treatment of RAO after transradial coronary catheterization (both angiography and percutaneous coronary intervention). It is a prospective, open label, randomized controlled trial that will randomize 60 patients with RAO, irrespective of symptoms, into two groups, one receiving anticoagulation with low-molecular-weight heparin and the other receiving no treatment. The primary end point is improvement in radial artery patency rate at 4 weeks after the procedure. Trial registration number: NCT04196309 (ClinicalTrials.gov)


Sign in / Sign up

Export Citation Format

Share Document